169 related articles for article (PubMed ID: 16497829)
1. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids.
Ghosh S; Bandulet C; Nitschke L
Int Immunol; 2006 Apr; 18(4):603-11. PubMed ID: 16497829
[TBL] [Abstract][Full Text] [Related]
2. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling.
Collins BE; Smith BA; Bengtson P; Paulson JC
Nat Immunol; 2006 Feb; 7(2):199-206. PubMed ID: 16369536
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-dependent inhibition of B cell proliferation requires CD22.
Santos L; Draves KE; Boton M; Grewal PK; Marth JD; Clark EA
J Immunol; 2008 Apr; 180(7):4561-9. PubMed ID: 18354178
[TBL] [Abstract][Full Text] [Related]
4. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
5. CD22 Controls Germinal Center B Cell Receptor Signaling, Which Influences Plasma Cell and Memory B Cell Output.
Meyer SJ; Steffensen M; Acs A; Weisenburger T; Wadewitz C; Winkler TH; Nitschke L
J Immunol; 2021 Aug; 207(4):1018-1032. PubMed ID: 34330755
[TBL] [Abstract][Full Text] [Related]
6. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
7. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.
Grewal PK; Boton M; Ramirez K; Collins BE; Saito A; Green RS; Ohtsubo K; Chui D; Marth JD
Mol Cell Biol; 2006 Jul; 26(13):4970-81. PubMed ID: 16782884
[TBL] [Abstract][Full Text] [Related]
8. A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: implications for B-cell homing to the bone marrow.
Floyd H; Nitschke L; Crocker PR
Immunology; 2000 Nov; 101(3):342-7. PubMed ID: 11106937
[TBL] [Abstract][Full Text] [Related]
9. Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions.
Alborzian Deh Sheikh A; Akatsu C; Imamura A; Abdu-Allah HHM; Takematsu H; Ando H; Ishida H; Tsubata T
Biochem Biophys Res Commun; 2018 Jan; 495(1):854-859. PubMed ID: 29146181
[TBL] [Abstract][Full Text] [Related]
10. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.
Haas KM; Johnson KL; Phipps JP; Do C
J Immunol; 2018 Mar; 200(5):1671-1681. PubMed ID: 29374074
[TBL] [Abstract][Full Text] [Related]
11. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells.
Nitschke L; Floyd H; Ferguson DJ; Crocker PR
J Exp Med; 1999 May; 189(9):1513-8. PubMed ID: 10224292
[TBL] [Abstract][Full Text] [Related]
12. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells.
Alborzian Deh Sheikh A; Akatsu C; Abdu-Allah HHM; Suganuma Y; Imamura A; Ando H; Takematsu H; Ishida H; Tsubata T
J Immunol; 2021 Jun; 206(11):2544-2551. PubMed ID: 33990399
[TBL] [Abstract][Full Text] [Related]
13. CD22 is a negative regulator of B-cell receptor signalling.
Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
[TBL] [Abstract][Full Text] [Related]
14. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
[TBL] [Abstract][Full Text] [Related]
15. Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells.
Enterina JR; Jung J; Macauley MS
Biomed J; 2019 Aug; 42(4):218-232. PubMed ID: 31627864
[TBL] [Abstract][Full Text] [Related]
16. Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.
Bednar KJ; Shanina E; Ballet R; Connors EP; Duan S; Juan J; Arlian BM; Kulis MD; Butcher EC; Fung-Leung WP; Rao TS; Paulson JC; Macauley MS
J Immunol; 2017 Nov; 199(9):3116-3128. PubMed ID: 28972089
[TBL] [Abstract][Full Text] [Related]
17. CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins.
Hanasaki K; Varki A; Powell LD
J Biol Chem; 1995 Mar; 270(13):7533-42. PubMed ID: 7706300
[TBL] [Abstract][Full Text] [Related]
18. Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model.
Wöhner M; Born S; Nitschke L
Eur J Immunol; 2012 Nov; 42(11):3009-18. PubMed ID: 22965838
[TBL] [Abstract][Full Text] [Related]
19. Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion.
Braesch-Andersen S; Stamenkovic I
J Biol Chem; 1994 Apr; 269(16):11783-6. PubMed ID: 8163475
[TBL] [Abstract][Full Text] [Related]
20. CD22: an inhibitory enigma.
Walker JA; Smith KG
Immunology; 2008 Mar; 123(3):314-25. PubMed ID: 18067554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
